3688 views | 9 years ago
Illumina would like to introduce our new addition — a 7-acre, 316,000 square-foot complex called the i3 campus. Consisting of three buildings, the i3 campus emphasizes openness, with ample windows to...
317 views | 9 years ago
Dr Eliezer Van Allen, Assistant Professor at Harvard Medical School and Medical Oncologist at the Dana Farber Cancer Institute, discusses his groundbreaking work in the genomics of cancer immunotherapy....
627 views | 9 years ago
Helene Peyro-Saint-Paul, MD, Chief Medical Officer of PathoQuest provides an overview of the development, validation and clinical evaluation of the iDTECT™ Blood Test. This test uses a next-genome sequencing...
343 views | 9 years ago
Illumina Accelerator graduate, Resilient Biotics, Inc., shares its experiences on launching a breakthrough genomics startup. Hear from Chris Belnap, PhD, CEO of Resilient Biotics about his journeys...
1049 views | 9 years ago
Discover the benefits of automated 16S rRNA amplicon and whole-genome sequencing methods for metagenomic analyses in this webinar. Dr Russell Carmical, Director of Operations for the Department of Molecular...
3248 views | 9 years ago
At Illumina, we want to inspire brilliant, passionate people to truly embrace our unique values and culture. Hear firsthand from our employees in Information Technology about why an IT career at Illumina...
1196 views | 9 years ago
Massively parallel sequencing (MPS) has become increasingly popular among forensic genomics laboratories. However, there are some challenges to implementation. Experts in the field of forensic genomics...
10777 views | 9 years ago
*For optimal viewing experience, watch it in VR on your mobile device. Update to the latest version of YouTube and click on the google cardboard icon to get started.* Experience the next era in sequencing...